Pharmacological management of type 2 diabetes mellitus: rationale for rational use of insulin. Mayo Clin Proc. 2003 Apr; 78(4):459-67.
Pharmacological management of type 2 diabetes mellitus: rationale for rational use of insulin.
Ritholz MD, Beverly EA, Abrahamson MJ, Brooks KM, Hultgren BA, Weinger K
Physicians' perceptions of the type 2 diabetes multi-disciplinary treatment team: a qualitative study. Diabetes Educ. 2011 Nov-Dec; 37(6):794-800.
Physicians' perceptions of the type 2 diabetes multi-disciplinary treatment team: a qualitative study.
A 74-year-old woman with diabetes. JAMA. 2007 Jan 10; 297(2):196-204.
Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, DeFronzo RA, Einhorn D, Fonseca VA, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2018 EXECUTIVE SUMMARY. Endocr Pract. 2018 01; 24(1):91-120.
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2018 EXECUTIVE SUMMARY.
Acute hyperglycemic crisis in the elderly. Med Clin North Am. 2004 Jul; 88(4):1063-84, xii.
Acute hyperglycemic crisis in the elderly.
Beverly EA, Ritholz MD, Brooks KM, Hultgren BA, Lee Y, Abrahamson MJ, Weinger K
A qualitative study of perceived responsibility and self-blame in type 2 diabetes: reflections of physicians and patients. J Gen Intern Med. 2012 Sep; 27(9):1180-7.
A qualitative study of perceived responsibility and self-blame in type 2 diabetes: reflections of physicians and patients.
Mehta SN, Goldfine AB, Abrahamson MJ, DiVincenzo R, Laffel LM
Journal of diabetes science and technology
Changing prescribing patterns of type 2 diabetes medications from 2002-2010: an electronic health record-based evaluation. J Diabetes Sci Technol. 2013 Jan 01; 7(1):119-22.
Changing prescribing patterns of type 2 diabetes medications from 2002-2010: an electronic health record-based evaluation.
Migdal A, Abrahamson M, Peters A, Vint N
Approaches to rapid acting insulin intensification in patients with type 2 diabetes mellitus not achieving glycemic targets. Ann Med. 2018 09; 50(6):453-460.
Approaches to rapid acting insulin intensification in patients with type 2 diabetes mellitus not achieving glycemic targets.
Beverly EA, Brooks KM, Ritholz MD, Abrahamson MJ, Weinger K
Assessment of emotional struggles in type 2 diabetes: patient perspectives. Diabetes Care. 2012 Aug; 35(8):e62.
Assessment of emotional struggles in type 2 diabetes: patient perspectives.
Mulligan GP, Davidson JS, Kaplan H, Abrahamson MJ
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde
Euthyroid hyperthyroxinaemia due to endogenous antibodies to thyroxine and tri-iodothyronine. A case report. S Afr Med J. 1989 Feb 18; 75(4):181-3.
Euthyroid hyperthyroxinaemia due to endogenous antibodies to thyroxine and tri-iodothyronine. A case report.
Ganda OP, Jumes CG, Abrahamson MJ, Molla M
Quantification of concordance and discordance between apolipoprotein-B and the currently recommended non-HDL-cholesterol goals for cardiovascular risk assessment in patients with diabetes and hypertriglyceridemia. Diabetes Res Clin Pract. 2012 Jul; 97(1):51-6.
Quantification of concordance and discordance between apolipoprotein-B and the currently recommended non-HDL-cholesterol goals for cardiovascular risk assessment in patients with diabetes and hypertriglyceridemia.
Beverly EA, Hultgren BA, Brooks KM, Ritholz MD, Abrahamson MJ, Weinger K
Understanding physicians' challenges when treating type 2 diabetic patients' social and emotional difficulties: a qualitative study. Diabetes Care. 2011 May; 34(5):1086-8.
Understanding physicians' challenges when treating type 2 diabetic patients' social and emotional difficulties: a qualitative study.
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2019 EXECUTIVE SUMMARY. Endocr Pract. 2019 01; 25(1):69-100.
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2019 EXECUTIVE SUMMARY.
Harvard T.H. Chan School of Public Health
Associate Professor in the Department of Epidemiology
Michael and Lee Bell Professor of Women's Health
Fredrick J. Stare Professor of Nutrition and Epidemiology
Clinical diabetes : a publication of the American Diabetes Association
Virtually Better Diabetes Care? Clin Diabetes. 2019 Jul; 37(3):284-286.
Mottalib A, Abrahamson MJ, Pober DM, Polak R, Eldib AH, Tomah S, Ashrafzadeh S, Hamdy O
Effect of diabetes-specific nutrition formulas on satiety and hunger hormones in patients with type 2 diabetes. Nutr Diabetes. 2019 09 24; 9(1):26.
Effect of diabetes-specific nutrition formulas on satiety and hunger hormones in patients with type 2 diabetes.
Harris S, Abrahamson MJ, Ceriello A, Charpentier G, Evans M, Lehmann R, Liebl A, Linjawi S, Holt RIG, Hosszúfalusi N, Rutten G, Vilsbøll T
Clinical Considerations When Initiating and Titrating Insulin Degludec/Liraglutide (IDegLira) in People with Type 2 Diabetes. Drugs. 2020 Feb; 80(2):147-165.
Clinical Considerations When Initiating and Titrating Insulin Degludec/Liraglutide (IDegLira) in People with Type 2 Diabetes.
Garber AJ, Handelsman Y, Grunberger G, Einhorn D, Abrahamson MJ, Barzilay JI, Blonde L, Bush MA, DeFronzo RA, Garber JR, Garvey WT, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Perreault L, Rosenblit PD, Samson S, Umpierrez GE
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2020 EXECUTIVE SUMMARY. Endocr Pract. 2020 01; 26(1):107-139.
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2020 EXECUTIVE SUMMARY.
Silva PS, Cavallerano JD, Sun JK, Tolson AM, Tolls D, Abrahamson MJ, Aiello LM, Aiello LP
Disparities Between Teleretinal Imaging Findings and Patient-Reported Diabetic Retinopathy Status and Follow-up Eye Care Interval: A 10-Year Prospective Study. Diabetes Care. 2024 Jun 01; 47(6):970-977.
Disparities Between Teleretinal Imaging Findings and Patient-Reported Diabetic Retinopathy Status and Follow-up Eye Care Interval: A 10-Year Prospective Study.
Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, Davidson MB, Einhorn D, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez G, Davidson MH
AACE comprehensive diabetes management algorithm 2013. Endocr Pract. 2013 Mar-Apr; 19(2):327-36.
AACE comprehensive diabetes management algorithm 2013.
Okeke EN, Keenan HA, Weinger K, Abrahamson MJ, Hsu WC
Do ethnic disparities extend to subspecialty diabetes care? Endocr Pract. 2013 May-Jun; 19(3):431-8.
Do ethnic disparities extend to subspecialty diabetes care?
Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, Davidson MB, Einhorn D, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE, Davidson MH
American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary. Endocr Pract. 2013 May-Jun; 19(3):536-57.
American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary.
Diabetes, prediabetes, and glycemic control in the United States: challenges and opportunities. Ann Intern Med. 2014 Apr 15; 160(8):572-3.
Diabetes, prediabetes, and glycemic control in the United States: challenges and opportunities.
Glycemic management in patients with coronary artery disease and prediabetes or type 2 diabetes mellitus. Circulation. 2014 Jun 17; 129(24):2567-73.
Glycemic management in patients with coronary artery disease and prediabetes or type 2 diabetes mellitus.
Halperin F, Ding SA, Simonson DC, Panosian J, Goebel-Fabbri A, Wewalka M, Hamdy O, Abrahamson M, Clancy K, Foster K, Lautz D, Vernon A, Goldfine AB
Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial. JAMA Surg. 2014 Jul; 149(7):716-26.
Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial.
Ritholz MD, Beverly EA, Brooks KM, Abrahamson MJ, Weinger K
Barriers and facilitators to self-care communication during medical appointments in the United States for adults with type 2 diabetes. Chronic Illn. 2014 Dec; 10(4):303-13.
Barriers and facilitators to self-care communication during medical appointments in the United States for adults with type 2 diabetes.
Polak R, Dill D, Abrahamson MJ, Pojednic RM, Phillips EM
Innovation in diabetes care: improving consumption of healthy food through a "chef coaching" program: a case report. Glob Adv Health Med. 2014 Nov; 3(6):42-8.
Innovation in diabetes care: improving consumption of healthy food through a "chef coaching" program: a case report.
Should sulfonylureas remain an acceptable first-line add-on to metformin therapy in patients with type 2 diabetes? Yes, they continue to serve us well! Diabetes Care. 2015 Jan; 38(1):166-9.
Should sulfonylureas remain an acceptable first-line add-on to metformin therapy in patients with type 2 diabetes? Yes, they continue to serve us well!
Smith CJ, Abrahamson MJ, Henshilwood PA, Bonnici F
The effect of an intensive education programme on the glycaemic control of type I diabetic patients. S Afr Med J. 1987 Feb 07; 71(3):164-6.
The effect of an intensive education programme on the glycaemic control of type I diabetic patients.
Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, Davidson MB, Einhorn D, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez G, Davidson MH
AACE/ACE comprehensive diabetes management algorithm 2015. Endocr Pract. 2015 Apr; 21(4):438-47.
AACE/ACE comprehensive diabetes management algorithm 2015.
The 2015 standards for diabetes care: maintaining a patient-centered approach. Ann Intern Med. 2015 Jun 02; 162(11):785-6.
The 2015 standards for diabetes care: maintaining a patient-centered approach.
Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, Davidson MB, Einhorn D, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2015 EXECUTIVE SUMMARY. Endocr Pract. 2015 Dec; 21(12):1403-14.
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2015 EXECUTIVE SUMMARY.
Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, DeFronzo RA, Einhorn D, Fonseca VA, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Henry RR, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2016 EXECUTIVE SUMMARY. Endocr Pract. 2016 Jan; 22(1):84-113.
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2016 EXECUTIVE SUMMARY.
Hsu WC, Lau KH, Huang R, Ghiloni S, Le H, Gilroy S, Abrahamson M, Moore J
Utilization of a Cloud-Based Diabetes Management Program for Insulin Initiation and Titration Enables Collaborative Decision Making Between Healthcare Providers and Patients. Diabetes Technol Ther. 2016 Feb; 18(2):59-67.
Utilization of a Cloud-Based Diabetes Management Program for Insulin Initiation and Titration Enables Collaborative Decision Making Between Healthcare Providers and Patients.
Mehta SN, Goldfine AB, Abrahamson MJ, McMullen W, Laffel LM
IMPROVEMENTS IN METABOLIC CONTROL IN ADULTS WITH TYPE 2 DIABETES FOLLOWING REFERRAL TO A DIABETES CENTER, 2005-2010. Endocr Pract. 2016 Jun; 22(6):689-98.
IMPROVEMENTS IN METABOLIC CONTROL IN ADULTS WITH TYPE 2 DIABETES FOLLOWING REFERRAL TO A DIABETES CENTER, 2005-2010.
Should We Screen for Type 2 Diabetes?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center. Ann Intern Med. 2016 10 04; 165(7):509-516.
Should We Screen for Type 2 Diabetes?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY. Endocr Pract. 2017 02; 23(2):207-238.
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY.
Mehta SN, Andersen HU, Abrahamson MJ, Wolpert HA, Hommel EE, McMullen W, Ridderstråle M
Changes in HbA1c and Weight Following Transition to Continuous Subcutaneous Insulin Infusion Therapy in Adults With Type 1 Diabetes. J Diabetes Sci Technol. 2017 01; 11(1):83-86.
Changes in HbA1c and Weight Following Transition to Continuous Subcutaneous Insulin Infusion Therapy in Adults With Type 1 Diabetes.
Polak R, Pober DM, Budd MA, Silver JK, Phillips EM, Abrahamson MJ
Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme
Improving patients' home cooking - A case series of participation in a remote culinary coaching program. Appl Physiol Nutr Metab. 2017 Aug; 42(8):893-896.
Improving patients' home cooking - A case series of participation in a remote culinary coaching program.
Durability of glycemic control: a feature of the thiazolidinediones. Diabetes Technol Ther. 2004 Apr; 6(2):179-89.
Durability of glycemic control: a feature of the thiazolidinediones.
Drexler AJ, Nesto RW, Abrahamson MJ, Bakris G, Bell D, Brunzell J, Dandona P, Davidson J, Fonseca V, Fowler M, Frye R, Giles T, Haffner S, Hollenberg N, Hsueh W, Law R, Plutzky J, Ratner R, Reusch J, Selwyn A, Sowers J, Wyne K, Young LH
Metabolic syndrome and related disorders
Evaluating the cardiovascular effects of the thiazolidinediones and their place in the management of type 2 diabetes in relation to the metabolic syndrome. Metab Syndr Relat Disord. 2005; 3(2):147-73.
Evaluating the cardiovascular effects of the thiazolidinediones and their place in the management of type 2 diabetes in relation to the metabolic syndrome.
Kumar R, Lee TT, Jeremias A, Ruisi CP, Sylvia B, Magallon J, Kirtane AJ, Bigelow B, Abrahamson M, Pinto DS, Ho KK, Cohen DJ, Carrozza JP, Cutlip DE
Comparison of outcomes using sirolimus-eluting stenting in diabetic versus nondiabetic patients with comparison of insulin versus non-insulin therapy in the diabetic patients. Am J Cardiol. 2007 Oct 15; 100(8):1187-91.
Comparison of outcomes using sirolimus-eluting stenting in diabetic versus nondiabetic patients with comparison of insulin versus non-insulin therapy in the diabetic patients.
Basal insulins: Pharmacological properties and patient perspectives. Prim Care Diabetes. 2010 Apr; 4 Suppl 1:S19-23.
Basal insulins: Pharmacological properties and patient perspectives.
Optimal glycemic control in type 2 diabetes mellitus: fasting and postprandial glucose in context. Arch Intern Med. 2004 Mar 08; 164(5):486-91.
Optimal glycemic control in type 2 diabetes mellitus: fasting and postprandial glucose in context.
Toward optimal health: the experts discuss important issues in hormone replacement and in diabetes. Interview by Jody R. Godfrey. J Womens Health (Larchmt). 2004 Dec; 13(10):1075-9.
Toward optimal health: the experts discuss important issues in hormone replacement and in diabetes. Interview by Jody R. Godfrey.
Insulin therapy for type 2 diabetes: making it work. J Fam Pract. 2010 Apr; 59(4):E1-8.
Insulin therapy for type 2 diabetes: making it work.
Mehta SS, Silver RJ, Aaronson A, Abrahamson M, Goldfine AB
Comparison of aspirin resistance in type 1 versus type 2 diabetes mellitus. Am J Cardiol. 2006 Feb 15; 97(4):567-70.
Comparison of aspirin resistance in type 1 versus type 2 diabetes mellitus.
Clinical use of thiazolidinediones: recommendations. Am J Med. 2003 Dec 08; 115 Suppl 8A:116S-120S.
Clinical use of thiazolidinediones: recommendations.
Insulin detemir: A historical perspective on a modern basal insulin analogue. Prim Care Diabetes. 2010 Apr; 4 Suppl 1:S31-42.
Insulin detemir: A historical perspective on a modern basal insulin analogue.
Intensification of insulin therapy in patients with type 2 diabetes mellitus: an algorithm for basal-bolus therapy. Ann Med. 2012 Dec; 44(8):836-46.
Intensification of insulin therapy in patients with type 2 diabetes mellitus: an algorithm for basal-bolus therapy.
Medicare coverage for patients with diabetes. A national plan with individual consequences. J Gen Intern Med. 2006 Apr; 21(4):386-92.
Medicare coverage for patients with diabetes. A national plan with individual consequences.